PT-141

PT-141 (Bremelanotide) is a synthetic peptide derived from the melanocortin peptide family, structurally related to analogs of alpha-melanocyte-stimulating hormone (α-MSH). It is studied in laboratory environments for its interaction with melanocortin receptors, particularly within pathways associated with central nervous system signaling and neuroendocrine activity.

In preclinical and clinical research settings, PT-141 has been investigated for how it may influence neural signaling pathways linked to melanocortin receptor activation. Unlike compounds that act primarily through vascular mechanisms, PT-141 has been studied for its activity at the central receptor level, making it of interest in research exploring brain-mediated signaling processes.

Researchers continue to examine PT-141 across several areas of study, including:

Due to its mechanism of action, PT-141 remains an important compound in melanocortin system research and neuro-signaling studies.

Product Information

Important Research Notice

This product is intended for laboratory research purposes only.

PT-141 is not approved for general human use outside of specific regulated medical contexts and is not intended to diagnose, treat, cure, or prevent any disease. All products offered by Genora Peptides are supplied strictly for in-vitro laboratory research conducted by qualified professionals.

⚠️ For Research Purposes Only: This product is intended for laboratory research use only. Not for human or animal consumption.